CCC

COLINZ LABORATORIES LTD.

No trades
See on Supercharts
Market capitalization
‪101.42 M‬INR
‪4.57 M‬INR
‪71.55 M‬INR
Beta (1Y)
1.07

About COLINZ LABORATORIES LTD.

CEO
Narayan Kutty Menon
Headquarters
Mumbai
Website
Employees (FY)
67
Founded
1986
ISIN
INE923C01011
FIGI
BBG000BGWYF5
Colinz Laboratories Ltd. engages in the manufacture of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectable, ointments, and creams. The firm has certain products for gynecology, cardiology, and gastroenterology. Its products category includes allopathy, ayurvedics, and nutraceuticals. The company was founded on October 6, 1986 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of COLINZ is 43.00 INR — it has increased by 6.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange COLINZ LABORATORIES LTD. stocks are traded under the ticker COLINZ.
COLINZ stock is 7.43% volatile and has beta coefficient of 1.07. Check out the list of the most volatile stocks — is COLINZ LABORATORIES LTD. there?
Yes, you can track COLINZ LABORATORIES LTD. financials in yearly and quarterly reports right on TradingView.
COLINZ stock has risen by 4.88% compared to the previous week, the month change is a 4.09% rise, over the last year COLINZ LABORATORIES LTD. has showed a 10.82% increase.
COLINZ net income for the last quarter is ‪1.06 M‬ INR, while the quarter before that showed ‪1.23 M‬ INR of net income which accounts for −13.72% change. Track more COLINZ LABORATORIES LTD. financial stats to get the full picture.
Today COLINZ LABORATORIES LTD. has the market capitalization of ‪101.42 M‬, it has increased by 5.75% over the last week.
No, COLINZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, COLINZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COLINZ LABORATORIES LTD. stock right from TradingView charts — choose your broker and connect to your account.
COLINZ reached its all-time high on Nov 7, 2022 with the price of 61.15 INR, and its all-time low was 2.06 INR and was reached on Jun 11, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 67.00 employees. See our rating of the largest employees — is COLINZ LABORATORIES LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COLINZ LABORATORIES LTD. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COLINZ LABORATORIES LTD. stock shows the strong buy signal. See more of COLINZ LABORATORIES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COLINZ LABORATORIES LTD. EBITDA is ‪5.78 M‬ INR, and current EBITDA margin is 8.84%. See more stats in COLINZ LABORATORIES LTD. financial statements.